Shenzhen AXBio Closes USD 100 Million Series B Round for Sequencing Tech Expansion
Shenzhen-based fourth-generation sequencing company Anxuyuan Biotechnology (shenzhen) Company Limited (AXBio) has reportedly secured close to...
Insight, China's Pharmaceutical Industry
Fineline Insights, Pharma Clarity